Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Johnson Matthey shares jump after trading update, strategic review of Health unit

Published 08/04/2021, 10:31
Updated 08/04/2021, 10:34
© Reuters.

By Samuel Indyk

Investing.com – Shares in Johnson Matthey were trading at the top of the FTSE 100 on Thursday morning after the company announced plans to conduct a strategic review of its Health business and provided a trading update for the year ending 31st March 2021.

In 2020/21 the company expects group operating performance to be around the top end of the market expectations. Despite the pandemic-related disruption, the company said the second half of the year was materially stronger, reflecting increased activity in autos and other key end markets.

“I am very pleased with the progress we made, particularly in the second half,” said Chief Executive Robert MacLeod. “As a result, group operating performance for the year is expected to be around the top end of market expectations, alongside continued strong management of working capital.”

Strategic review of Health business

The company said it continues to review its portfolio to focus on areas of greatest opportunity ad maximise value for shareholders. As a result of this, Johnson Matthey PLC (LON:JMAT) said it will be undertaking a strategic review of its Health business.

Strategic shift?

One of the company’s major revenue drivers is catalytic converters but as markets shift towards more electric vehicles and fewer vehicles with internal combustion engines, the company has had to shift towards newer technologies.

“Johnson Matthey is pivoting its business toward supplying materials for batteries and hydrogen fuel cells, an expensive, but necessary transition,” said Laura Hoy, equity analyst at {0|Hargreaves Lansdown }}. “As it stands, New Markets, the division that houses these segments, makes up only a fraction of the group’s overall revenue. But the group has been investing heavily on increased manufacturing capacity for both fuel cell and battery components.”

Some have suggested that a potential sale of the Health business could help fund the company’s move towards electric vehicles.

“We wonder if potential sale proceeds would be used to ramp up its EV transition, or if management is hoping to unearth a new growth opportunity outside autos,” Hoy added. “The former makes sense, considering JMAT’s entrenchment in the auto industry.”

At 10:30BST, Johnson Matthey shares were trading 3.3% higher at 3,200p

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.